Literature DB >> 3568693

A two-stage design for randomized trials with binary outcomes.

S Wieand, T Therneau.   

Abstract

A two-stage rule for a randomized clinical trial with a dichotomous outcome is presented. It is based on a rule discussed by Ellenberg and Eisenberger (Cancer Treat Rep 69:1147-1154, 1985). The rule is shown to lead to a reduction in expected sample size if the test treatment is ineffective, with almost no loss in power. All the mathematical formulas required to design such a rule are given, as well as some time-saving approximations. The accuracy of the approximations is shown.

Entities:  

Mesh:

Year:  1987        PMID: 3568693     DOI: 10.1016/0197-2456(87)90022-5

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  5 in total

1.  Resampling phase III data to assess phase II trial designs and endpoints.

Authors:  Manish R Sharma; Theodore G Karrison; Yuyan Jin; Robert R Bies; Michael L Maitland; Walter M Stadler; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2012-01-27       Impact factor: 12.531

2.  Lifetime data analysis. Editorial.

Authors:  David Harrington; Mitchell H Gail
Journal:  Lifetime Data Anal       Date:  2008-01-25       Impact factor: 1.588

3.  A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.

Authors:  Jonas A de Souza; Darren W Davis; Yujian Zhang; Arun Khattri; Tanguy Y Seiwert; Serdal Aktolga; Stuart J Wong; Mark F Kozloff; Sreenivasa Nattam; Mark W Lingen; Rangesh Kunnavakkam; Kerstin M Stenson; Elizabeth A Blair; Jeffrey Bozeman; Janet E Dancey; Everett E Vokes; Ezra E W Cohen
Journal:  Clin Cancer Res       Date:  2012-02-27       Impact factor: 12.531

4.  Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

Authors:  S J Wong; T Karrison; D N Hayes; M S Kies; K J Cullen; T Tanvetyanon; A Argiris; N Takebe; D Lim; N F Saba; F P Worden; J Gilbert; H J Lenz; A R A Razak; J D Roberts; E E Vokes; E E W Cohen
Journal:  Ann Oncol       Date:  2015-11-23       Impact factor: 32.976

Review 5.  Basic design considerations for clinical trials in oncology.

Authors:  S Piantadosi; N Saijo; T Tamura
Journal:  Jpn J Cancer Res       Date:  1992-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.